GIPR expression in gastric and duodenal neuroendocrine tumors.
about
Pancreastatin predicts survival in neuroendocrine tumors.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression.Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.
P2860
GIPR expression in gastric and duodenal neuroendocrine tumors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
GIPR expression in gastric and duodenal neuroendocrine tumors.
@en
GIPR expression in gastric and duodenal neuroendocrine tumors.
@nl
type
label
GIPR expression in gastric and duodenal neuroendocrine tumors.
@en
GIPR expression in gastric and duodenal neuroendocrine tumors.
@nl
prefLabel
GIPR expression in gastric and duodenal neuroendocrine tumors.
@en
GIPR expression in gastric and duodenal neuroendocrine tumors.
@nl
P2093
P2860
P50
P1476
GIPR expression in gastric and duodenal neuroendocrine tumors.
@en
P2093
Donghong Wang
Jennifer C Carr
Jessica E Maxwell
Scott K Sherman
P2860
P304
P356
10.1016/J.JSS.2014.01.044
P577
2014-01-29T00:00:00Z